Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
04/11/2002 | US20020042095 Polypeptide for use as wound healing agent; for use in the modulation of inflammation, infection and immunity |
04/11/2002 | US20020042094 Nucleotide sequences for use in the detection and treatment cancer |
04/11/2002 | US20020042093 Polypeptide; for use in diagnosis, treatment or prevention of thyroid tumors and defects |
04/11/2002 | US20020042087 Inducing preferential cell proliferation; obtain preferential cells, incubate with modulator, monitor cell sample for proliferation activity |
04/11/2002 | US20020042066 Polypeptide for use in diagnosis, prevention, and treatment of tissue damage and cancer |
04/11/2002 | US20020042064 p53 binding areas |
04/11/2002 | US20020042062 Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
04/11/2002 | US20020042058 18057 protein, a novel seven transmembrane protein |
04/11/2002 | US20020042057 Nucleotide sequences for use in the treatment of cardiomyopathies |
04/11/2002 | US20020042049 Reagents and methods useful for detecting diseases of the breast |
04/11/2002 | US20020042046 Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex |
04/11/2002 | US20020042045 METHODS FOR THE DETECTION OF HTLV-II ANTIBODIES EMPLOYIING NOVEL HTLV-II nra ENVELOPE PEPTIDES |
04/11/2002 | US20020041882 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
04/11/2002 | US20020041881 Identification and characterization of novel pneumococcal choline binding protein, cbpg, and diagnostic and therapeutic uses thereof |
04/11/2002 | US20020041876 Modulation of angiogenesis |
04/11/2002 | US20020041874 Administering integrin antagonist |
04/11/2002 | US20020041870 Novel genes expressed in obese rat hypothalamus |
04/11/2002 | US20020041865 Methods for treating tumors |
04/11/2002 | DE10132724A1 Für das dctA-Gen kodierende Nukleotidsequenzen For the dctA gene encoding nucleotide sequences |
04/11/2002 | DE10123070A1 Neue für das atr43-Gen kodierende Nukleotidsequenzen New coding for the atr43 gene nucleotide sequences |
04/11/2002 | DE10048950A1 Activating p53-responsive promoter, useful for treating tumors that contain mutant forms of p53, using an adaptor protein that links the promoter to mutated p53 |
04/11/2002 | DE10048893A1 New nucleic acids involved in neuronal regeneration, useful in screening for modulators of regeneration or synaptic efficiency, and potential therapeutic agents |
04/11/2002 | DE10048417A1 Verbindungen mit verzweigtem Linker Compounds with branched linker |
04/11/2002 | DE10048214A1 Pflanzen mit maskierter Fruchtbarkeit Plants with masked fertility |
04/11/2002 | DE10047866A1 Neue für das dep67-Gen kodierende Nukleotidsequenzen New coding for the dep67 gene nucleotide sequences |
04/11/2002 | DE10047404A1 Neue für das msik-Gen kodierende Nukleotidsequenzen New coding for the msiK gene nucleotide sequences |
04/11/2002 | DE10047142A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure unter Verwendung coryneformer Bakterien A process for the fermentative preparation of D-pantothenic acid using coryneform bacteria |
04/11/2002 | DE10046970A1 New human P2Y1li gene, useful for treatment and diagnosis of associated diseases, and related proteins, antibodies and modulators, encodes G protein-coupled receptor |
04/11/2002 | DE10046625A1 Neue für das ndkA-Gen kodierende Nukleotidsequenzen New coding for the ndkA gene nucleotide sequences |
04/11/2002 | DE10045803A1 New proteins binding specifically to the ED-b fibronectin domain, are cell adhesion and proliferation mediators useful e.g. in screening tests |
04/11/2002 | DE10045579A1 Neue für das atr61-Gen kodierende Nukleotidsequenzen New coding for the atr61 gene nucleotide sequences |
04/11/2002 | DE10045487A1 Neue für das ccsB-Gen kodierende Nukleotidsequenzen New coding for the CCSB gene nucleotide sequences |
04/11/2002 | DE10045486A1 Neue für das pstC2-Gen kodierende Nukleotidsequenzen New coding for the pstC2 gene nucleotide sequences |
04/11/2002 | CA2448483A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
04/11/2002 | CA2426621A1 Drug resistance-associated gene and use thereof |
04/11/2002 | CA2425712A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
04/11/2002 | CA2425269A1 G-protein coupled receptors |
04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
04/11/2002 | CA2425152A1 Highly expressible genes |
04/11/2002 | CA2425124A1 Selective anxiolytic therapeutic agents |
04/11/2002 | CA2425092A1 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
04/11/2002 | CA2424974A1 A nitrate-responsive plant root specific transcriptional factor |
04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
04/11/2002 | CA2424890A1 Ethanol production in gram-positive bacteria with a stabilized mutation in lactate dehydrogenase |
04/11/2002 | CA2424834A1 Nogo receptor homologs |
04/11/2002 | CA2424730A1 Compositions and methods for the transport of biologically active agents across cellular barriers |
04/11/2002 | CA2424668A1 Targeting molecules for adenoviral vectors |
04/11/2002 | CA2424546A1 G-protein fusion receptors and chimeric gabab receptors |
04/11/2002 | CA2424545A1 Chlamydia pmp proteins, gene sequences and uses thereof |
04/11/2002 | CA2424543A1 Component for vaccine |
04/11/2002 | CA2424506A1 Cyclopeptides, a method for their preparation and their use as inhibitors or activators of angiogenesis |
04/11/2002 | CA2424275A1 Haemophilus influenzae antigens and corresponding dna fragments |
04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
04/11/2002 | CA2423675A1 Methods for detecting vasculopathies and tumors |
04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
04/11/2002 | CA2422707A1 Regioselective liquid phase pegylation |
04/11/2002 | CA2422642A1 Human prostate specific g-protein receptor hpraj70 |
04/11/2002 | CA2421147A1 24 human secreted proteins |
04/11/2002 | CA2358860A1 Dna-binding protein yb-1-containing collagen accumulation inhibitors |
04/10/2002 | EP1195440A1 Gene delivery vectors for stem cells |
04/10/2002 | EP1195439A2 Retroviral vector with heterologous sequences between the retroviral primer binding site and the retroviral splice donor site |
04/10/2002 | EP1195438A1 Genetic immunisation against cervical carcinoma |
04/10/2002 | EP1195437A1 Process for the recombinant production of proteins using a Plac/Np hybrid promoter |
04/10/2002 | EP1195433A2 Respiratory chain enzyme genes of coryneform bacteria |
04/10/2002 | EP1195384A1 Snake proteins having antithrombotic activity |
04/10/2002 | EP1195383A2 Three-dimensional structure of bovine rhodopsin |
04/10/2002 | EP1195382A2 Testis-specific gene |
04/10/2002 | EP1195381A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes |
04/10/2002 | EP1195168A2 Ternary radiopharmaceutical complexes |
04/10/2002 | EP1195163A1 Serine protease inhibitor |
04/10/2002 | EP1195161A2 Anti-IgE vaccines |
04/10/2002 | EP1195097A1 Continuous direct enzymatic protein solubilisation process for industrial waste |
04/10/2002 | EP1194777A1 Methods and compositions relating to pancreatic islet and beta-cell dysfunction |
04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
04/10/2002 | EP1194575A1 Modified human granulocyte-colony stimulating factor and process for producing same |
04/10/2002 | EP1194572A2 Promoter sequences derived from fusarium venenatum and uses thereof |
04/10/2002 | EP1194571A1 Prostase vaccine |
04/10/2002 | EP1194570A1 Fusion proteins incorporating lysozyme |
04/10/2002 | EP1194569A2 Seripancrin |
04/10/2002 | EP1194563A1 Fimh adhesin-based vaccines |
04/10/2002 | EP1194562A1 The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells |
04/10/2002 | EP1194561A2 Donor strand complemented pilin and adhesin broad-based vaccines |
04/10/2002 | EP1194560A2 Antigenic neisserial peptides |
04/10/2002 | EP1194559A1 Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
04/10/2002 | EP1194558A2 Novel sgs3 plant gene and use thereof |
04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
04/10/2002 | EP1194556A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
04/10/2002 | EP1194555A1 Methods for making apo-2 ligand using divalent metal ions |
04/10/2002 | EP1194554A1 Delivery of trefoil peptides |
04/10/2002 | EP1194553A1 Polypeptides and polynucleotides related to a glycine transporter |
04/10/2002 | EP1194552A1 Nucleic acids coding for peptides having the biological activity of sorbin |
04/10/2002 | EP1194551A1 G-protein coupled receptor and dna sequences thereof |
04/10/2002 | EP1194550A1 Antimicrobial peptides derived from molluscs |
04/10/2002 | EP1194549A2 Human genes and gene expression products |
04/10/2002 | EP1194548A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |